Adult and Pediatric Vaccines Industry Research Report 2025
Description
Summary
According to APO Research, The global Adult and Pediatric Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Adult and Pediatric Vaccines include Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Sinovac Biotech, AstraZeneca and Takeda Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Adult and Pediatric Vaccines Segment by Company
Sanofi Johnson and Johnson Novartis Merck Pfizer GlaxoSmithKline Sinovac Biotech AstraZeneca Takeda Pharmaceutical LG Life Sciences Bavarian NordicAdult and Pediatric Vaccines Segment by Type
Adult Vaccines Pediatric VaccinesAdult and Pediatric Vaccines Segment by Application
Hospitals Medical Care Centers OthersAdult and Pediatric Vaccines Segment by Application
Hospitals Medical Care Centers OthersAdult and Pediatric Vaccines Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult and Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Adult and Pediatric Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global Adult and Pediatric Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Adult and Pediatric Vaccines include Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Sinovac Biotech, AstraZeneca and Takeda Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Adult and Pediatric Vaccines Segment by Company
Sanofi Johnson and Johnson Novartis Merck Pfizer GlaxoSmithKline Sinovac Biotech AstraZeneca Takeda Pharmaceutical LG Life Sciences Bavarian NordicAdult and Pediatric Vaccines Segment by Type
Adult Vaccines Pediatric VaccinesAdult and Pediatric Vaccines Segment by Application
Hospitals Medical Care Centers OthersAdult and Pediatric Vaccines Segment by Application
Hospitals Medical Care Centers OthersAdult and Pediatric Vaccines Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult and Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Adult and Pediatric Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
122 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Adult and Pediatric Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 Adult Vaccines
- 2.2.3 Pediatric Vaccines
- 2.3 Adult and Pediatric Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Hospitals
- 2.3.3 Medical Care Centers
- 2.3.4 Others
- 2.4 Assumptions and Limitations
- 3 Adult and Pediatric Vaccines Breakdown Data by Type
- 3.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2020-2025)
- 3.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031)
- 4 Adult and Pediatric Vaccines Breakdown Data by Application
- 4.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2020-2025)
- 4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global Adult and Pediatric Vaccines Market Perspective (2020-2031)
- 5.2 Global Adult and Pediatric Vaccines Growth Trends by Region
- 5.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 Adult and Pediatric Vaccines Historic Market Size by Region (2020-2025)
- 5.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031)
- 5.3 Adult and Pediatric Vaccines Market Dynamics
- 5.3.1 Adult and Pediatric Vaccines Industry Trends
- 5.3.2 Adult and Pediatric Vaccines Market Drivers
- 5.3.3 Adult and Pediatric Vaccines Market Challenges
- 5.3.4 Adult and Pediatric Vaccines Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Adult and Pediatric Vaccines Players by Revenue
- 6.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2020-2025)
- 6.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2025)
- 6.2 Global Adult and Pediatric Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Adult and Pediatric Vaccines Head Office and Area Served
- 6.4 Global Adult and Pediatric Vaccines Players, Product Type & Application
- 6.5 Global Adult and Pediatric Vaccines Manufacturers Established Date
- 6.6 Global Adult and Pediatric Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Adult and Pediatric Vaccines Market Size (2020-2031)
- 7.2 North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America Adult and Pediatric Vaccines Market Size by Country (2020-2025)
- 7.4 North America Adult and Pediatric Vaccines Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe Adult and Pediatric Vaccines Market Size (2020-2031)
- 8.2 Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025)
- 8.4 Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2020-2031)
- 9.2 Asia-Pacific Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Country (2020-2025)
- 9.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America Adult and Pediatric Vaccines Market Size (2020-2031)
- 10.2 South America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America Adult and Pediatric Vaccines Market Size by Country (2020-2025)
- 10.4 South America Adult and Pediatric Vaccines Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2020-2031)
- 11.2 Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025)
- 11.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 Sanofi
- 12.1.1 Sanofi Company Information
- 12.1.2 Sanofi Business Overview
- 12.1.3 Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.1.4 Sanofi Adult and Pediatric Vaccines Product Portfolio
- 12.1.5 Sanofi Recent Developments
- 12.2 Johnson and Johnson
- 12.2.1 Johnson and Johnson Company Information
- 12.2.2 Johnson and Johnson Business Overview
- 12.2.3 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.2.4 Johnson and Johnson Adult and Pediatric Vaccines Product Portfolio
- 12.2.5 Johnson and Johnson Recent Developments
- 12.3 Novartis
- 12.3.1 Novartis Company Information
- 12.3.2 Novartis Business Overview
- 12.3.3 Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.3.4 Novartis Adult and Pediatric Vaccines Product Portfolio
- 12.3.5 Novartis Recent Developments
- 12.4 Merck
- 12.4.1 Merck Company Information
- 12.4.2 Merck Business Overview
- 12.4.3 Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.4.4 Merck Adult and Pediatric Vaccines Product Portfolio
- 12.4.5 Merck Recent Developments
- 12.5 Pfizer
- 12.5.1 Pfizer Company Information
- 12.5.2 Pfizer Business Overview
- 12.5.3 Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.5.4 Pfizer Adult and Pediatric Vaccines Product Portfolio
- 12.5.5 Pfizer Recent Developments
- 12.6 GlaxoSmithKline
- 12.6.1 GlaxoSmithKline Company Information
- 12.6.2 GlaxoSmithKline Business Overview
- 12.6.3 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.6.4 GlaxoSmithKline Adult and Pediatric Vaccines Product Portfolio
- 12.6.5 GlaxoSmithKline Recent Developments
- 12.7 Sinovac Biotech
- 12.7.1 Sinovac Biotech Company Information
- 12.7.2 Sinovac Biotech Business Overview
- 12.7.3 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.7.4 Sinovac Biotech Adult and Pediatric Vaccines Product Portfolio
- 12.7.5 Sinovac Biotech Recent Developments
- 12.8 AstraZeneca
- 12.8.1 AstraZeneca Company Information
- 12.8.2 AstraZeneca Business Overview
- 12.8.3 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.8.4 AstraZeneca Adult and Pediatric Vaccines Product Portfolio
- 12.8.5 AstraZeneca Recent Developments
- 12.9 Takeda Pharmaceutical
- 12.9.1 Takeda Pharmaceutical Company Information
- 12.9.2 Takeda Pharmaceutical Business Overview
- 12.9.3 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.9.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Product Portfolio
- 12.9.5 Takeda Pharmaceutical Recent Developments
- 12.10 LG Life Sciences
- 12.10.1 LG Life Sciences Company Information
- 12.10.2 LG Life Sciences Business Overview
- 12.10.3 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.10.4 LG Life Sciences Adult and Pediatric Vaccines Product Portfolio
- 12.10.5 LG Life Sciences Recent Developments
- 12.11 Bavarian Nordic
- 12.11.1 Bavarian Nordic Company Information
- 12.11.2 Bavarian Nordic Business Overview
- 12.11.3 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025)
- 12.11.4 Bavarian Nordic Adult and Pediatric Vaccines Product Portfolio
- 12.11.5 Bavarian Nordic Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Adult and Pediatric Vaccines Market Size by Type (2020-2025) & (US$ Million)
- Table 6. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2020-2025)
- Table 7. Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
- Table 8. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2026-2031)
- Table 9. Global Adult and Pediatric Vaccines Market Size by Application (2020-2025) & (US$ Million)
- Table 10. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2020-2025)
- Table 11. Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
- Table 12. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2026-2031)
- Table 13. Global Adult and Pediatric Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 14. Global Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)
- Table 15. Global Adult and Pediatric Vaccines Market Share by Region (2020-2025)
- Table 16. Global Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
- Table 17. Global Adult and Pediatric Vaccines Market Share by Region (2026-2031)
- Table 18. Adult and Pediatric Vaccines Industry Trends
- Table 19. Adult and Pediatric Vaccines Industry Drivers
- Table 20. Adult and Pediatric Vaccines Industry Opportunities and Challenges
- Table 21. Adult and Pediatric Vaccines Market Restraints
- Table 22. Global Top Adult and Pediatric Vaccines Players by Revenue (US$ Million) & (2020-2025)
- Table 23. Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2025)
- Table 24. Global Adult and Pediatric Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- Table 25. Global Key Players of Adult and Pediatric Vaccines, Headquarters and Area Served
- Table 26. Global Adult and Pediatric Vaccines Players, Product Type & Application
- Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
- Table 28. Global Adult and Pediatric Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 29. Players Mergers & Acquisitions, Expansion Plans
- Table 30. North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 31. North America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
- Table 32. North America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
- Table 33. Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 34. Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
- Table 35. Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
- Table 36. Asia Pacific Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 37. Asia Pacific Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)
- Table 38. Asia Pacific Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
- Table 39. South America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 40. South America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
- Table 41. South America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
- Table 42. Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 43. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
- Table 44. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
- Table 45. Sanofi Company Information
- Table 46. Sanofi Business Overview
- Table 47. Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 48. Sanofi Adult and Pediatric Vaccines Product Portfolio
- Table 49. Sanofi Recent Developments
- Table 50. Johnson and Johnson Company Information
- Table 51. Johnson and Johnson Business Overview
- Table 52. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 53. Johnson and Johnson Adult and Pediatric Vaccines Product Portfolio
- Table 54. Johnson and Johnson Recent Developments
- Table 55. Novartis Company Information
- Table 56. Novartis Business Overview
- Table 57. Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 58. Novartis Adult and Pediatric Vaccines Product Portfolio
- Table 59. Novartis Recent Developments
- Table 60. Merck Company Information
- Table 61. Merck Business Overview
- Table 62. Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 63. Merck Adult and Pediatric Vaccines Product Portfolio
- Table 64. Merck Recent Developments
- Table 65. Pfizer Company Information
- Table 66. Pfizer Business Overview
- Table 67. Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 68. Pfizer Adult and Pediatric Vaccines Product Portfolio
- Table 69. Pfizer Recent Developments
- Table 70. GlaxoSmithKline Company Information
- Table 71. GlaxoSmithKline Business Overview
- Table 72. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 73. GlaxoSmithKline Adult and Pediatric Vaccines Product Portfolio
- Table 74. GlaxoSmithKline Recent Developments
- Table 75. Sinovac Biotech Company Information
- Table 76. Sinovac Biotech Business Overview
- Table 77. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 78. Sinovac Biotech Adult and Pediatric Vaccines Product Portfolio
- Table 79. Sinovac Biotech Recent Developments
- Table 80. AstraZeneca Company Information
- Table 81. AstraZeneca Business Overview
- Table 82. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 83. AstraZeneca Adult and Pediatric Vaccines Product Portfolio
- Table 84. AstraZeneca Recent Developments
- Table 85. Takeda Pharmaceutical Company Information
- Table 86. Takeda Pharmaceutical Business Overview
- Table 87. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 88. Takeda Pharmaceutical Adult and Pediatric Vaccines Product Portfolio
- Table 89. Takeda Pharmaceutical Recent Developments
- Table 90. LG Life Sciences Company Information
- Table 91. LG Life Sciences Business Overview
- Table 92. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 93. LG Life Sciences Adult and Pediatric Vaccines Product Portfolio
- Table 94. LG Life Sciences Recent Developments
- Table 95. Bavarian Nordic Company Information
- Table 96. Bavarian Nordic Business Overview
- Table 97. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
- Table 98. Bavarian Nordic Adult and Pediatric Vaccines Product Portfolio
- Table 99. Bavarian Nordic Recent Developments
- Table 100. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Adult and Pediatric Vaccines Product Image
- Figure 5. Global Adult and Pediatric Vaccines Market Size Comparison by Type (2025-2031) & (US$ Million)
- Figure 6. Global Adult and Pediatric Vaccines Market Share by Type: 2024 VS 2031
- Figure 7. Adult Vaccines Product
- Figure 8. Pediatric Vaccines Product
- Figure 9. Global Adult and Pediatric Vaccines Market Size by Application (2025-2031) & (US$ Million)
- Figure 10. Global Adult and Pediatric Vaccines Market Share by Application: 2024 VS 2031
- Figure 11. Hospitals Product
- Figure 12. Medical Care Centers Product
- Figure 13. Others Product
- Figure 14. Global Adult and Pediatric Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
- Figure 15. Global Adult and Pediatric Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
- Figure 16. Global Adult and Pediatric Vaccines Market Share by Region: 2024 VS 2031
- Figure 17. Global Adult and Pediatric Vaccines Market Share by Players in 2024
- Figure 18. Global Adult and Pediatric Vaccines Manufacturers Established Date
- Figure 19. Global Top 5 and 10 Adult and Pediatric Vaccines Players Market Share by Revenue in 2024
- Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 21. North America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 22. North America Adult and Pediatric Vaccines Market Share by Country (2020-2031)
- Figure 23. United States Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 24. Canada Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 25. Mexico Adult and Pediatric Vaccines Market Share by Country (2020-2031)
- Figure 26. Europe Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 27. Europe Adult and Pediatric Vaccines Market Share by Country (2020-2031)
- Figure 28. Germany Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 29. France Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 30. U.K. Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 31. Italy Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 32. Spain Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 33. Russia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 34. Netherlands Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 35. Nordic Countries Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 36. Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 37. Asia-Pacific Adult and Pediatric Vaccines Market Share by Country (2020-2031)
- Figure 38. China Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 39. Japan Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 40. South Korea Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 41. India Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 42. India Adult and Pediatric Vaccines Market Share by Country (2020-2031)
- Figure 43. Australia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 44. China Taiwan Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 45. Southeast Asia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 46. South America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 47. South America Adult and Pediatric Vaccines Market Share by Country (2020-2031)
- Figure 48. Brazil Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 49. Argentina Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 50. Chile Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 51. Colombia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 52. Peru Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
- Figure 53. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 54. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 55. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 56. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 57. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 58. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 59. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 60. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 61. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 62. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
- Figure 63. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

